OTCMKTS:DMTTF Small Pharma (DMTTF) Stock Price, News & Analysis $0.11 0.00 (0.00%) As of 10/25/2023 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Small Pharma Stock (OTCMKTS:DMTTF) Get Small Pharma alerts:Sign Up Key Stats Today's Range$0.11▼$0.1150-Day Range$0.11▼$0.1152-Week Range$0.05▼$0.19VolumeN/AAverage Volume113,204 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Small Pharma is a clinical-stage biotechnology company focused on the discovery and development of next-generation therapeutics inspired by psychedelic compounds. The company applies proprietary medicinal chemistry and formulation technologies to create novel small-molecule derivatives of naturally occurring tryptamines, with the aim of harnessing their potential to treat a variety of neurological and psychiatric disorders. Its pipeline comprises lead candidates in preclinical development designed to address acute brain injury, neurodegenerative diseases and mood disorders. These molecules are engineered to modulate neural inflammation, promote neuroregeneration and restore synaptic function, with potential applications in conditions such as traumatic brain injury, stroke and treatment-resistant depression. Headquartered in Oxford, United Kingdom, Small Pharma collaborates with academic research centres and contract research organizations to advance its pharmacology, toxicology and manufacturing programs. The company has secured a portfolio of patent applications to protect its intellectual property across key global markets. The leadership team brings together experienced professionals from pharmaceutical research, clinical development and operational management, supporting the progression of Small Pharma’s candidates toward human clinical trials. The company’s shares trade on the OTC Markets under the ticker DMTTF.AI Generated. May Contain Errors. Read More Receive DMTTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Small Pharma and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DMTTF Stock News HeadlinesTrump’s Tariffs Would Spare Many Rich Drugmakers While Punishing Some Small OnesSeptember 26, 2025 | nytimes.comBig Pharma Unfazed by Trump Tariffs, but Small Biotechs Face VulnerabilitySeptember 26, 2025 | msn.comThis Crypto Is Set to Explode in JanuaryThe crypto summit Wall Street wants to stop Learn how to structure your portfolio like the top hedge funds.October 16 at 2:00 AM | Crypto 101 Media (Ad)US to initially impose 'small tariff' on pharma imports, Trump saysAugust 5, 2025 | msn.comTop 5 Small-cap Pharma Stocks in 2025April 8, 2025 | msn.comAfter setback, Durham pharma tries again for FDA approvalNovember 1, 2024 | bizjournals.comPBM math: Big chains pay $23.55 to fill a blood pressure Rx. Small drugstores? $1.51October 28, 2024 | msn.comTNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to MarketOctober 2, 2024 | businesswire.comSee More Headlines DMTTF Stock Analysis - Frequently Asked Questions How have DMTTF shares performed this year? Small Pharma's stock was trading at $0.1117 at the beginning of the year. Since then, DMTTF stock has increased by 0.0% and is now trading at $0.1117. How do I buy shares of Small Pharma? Shares of DMTTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:DMTTF CIKN/A Webwww.smallpharma.co.uk PhoneN/AFaxN/AEmployees13Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (OTCMKTS:DMTTF) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Small Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Small Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.